课题基金 / 基金详情

项目摘要

项目成果

STEVEN H FERRIS的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):自1990年以来,纽约大学ADC一直为一项关于老龄化和AD的综合、多学科研究项目提供核心资源和支持,该项目涵盖基础研究和心理社会研究。ADC的主要科学目标是促进和加强有助于早期诊断和预防的研究。在未来5年内,核心资源将用于研究从正常衰老到轻度认知障碍(MCI)和早期AD的过渡。除了纽约大学索姆,内森·克莱恩研究所(NKI)、纽约基础研究所(IBR)和纽约地区其他机构的调查人员也参与了调查。对AD及相关疾病患者、MCI受试者和认知正常受试者进行纵向解剖研究。在执行委员会和外部咨询委员会任职的一名董事和协理领导监督香港艺术发展局。支持的标准ADC核心包括管理、临床、神经病理学、数据管理和教育核心。此外,神经成像和Caregiver核心显著加强了ADC研究人员的研究贡献。临床核心包括一个专注于少数族裔招募的卫星多元文化计划,以及一个ADC生物库(由临床、神经成像和神经病理学核心共同努力)存储并为研究人员提供脑脊液、血液和尸检脑组织样本。神经病理学核心包括IBR的形态测量部分。每年,ADC直接支持几项试点研究,并提供核心资源(受试者;临床、神经成像和心理社会数据;血液、脑脊液和脑组织),以广泛的当前研究得到NIH和其他来源的主要支持。通过创建脑老化卓越中心,利用ADC进行的广泛的多学科研究得到了加强。还与其他ADC和国家财团进行了广泛的合作,来自纽约大学ADC的数据与国家阿尔茨海默氏症协调中心(NACC)和许多合作调查人员共享。香港艺术发展局已经并将继续为消除AD问题作出重大贡献。
英文摘要
DESCRIPTION (provided by applicant): Since 1990, the ADC at NYU has been providing core resources and support to a comprehensive, multidisciplinary research program on aging and AD that spans basic through psychosocial research. The main scientific goal of the ADC is to facilitate and enhance research that will lead to early diagnosis and prevention. Over the next 5-years, core resources will be used to study the transition from normal aging to mild cognitive impairment (MCI) and early AD. In addition to NYU SoM, investigators at the Nathan Kline Institute (NKI), the NYS Institute for Basic Research (IBR), and other New York City area facilities are also participating. Patients with AD and related disorders, subjects with MCI, and cognitively normal subjects are studied longitudinally through postmortem. A Director and Associate Leaders who serve on an Executive Committee and an External Advisory Committee supervise the ADC. Standard ADC cores supported consist of Administrative, Clinical, Neuropathology, Data Management and Education Cores. In addition, Neuroimaging and Caregiver Cores significantly strengthen the research contributions of ADC investigators. The Clinical Core includes a Satellite Multicultural Program focusing on minority recruitment, and an ADC Biorepository (a joint effort of the Clinical, Neuroimaging and Neuropathology Cores) stores and provides investigators with CSF, blood and postmortem brain tissue samples. The Neuropathology Core includes a morphometry component at IBR. Each year, the ADC directly supports several pilot studies, and provides core resources (subjects; clinical, neuroimaging and psychosocial data; blood, CSF and brain tissue) to extensive current research receiving primary support from NIH and other sources. The extensive multidisciplinary research utilizing the ADC has been strengthened by the creation of a Center of Excellence on Brain Aging. There is also extensive collaboration with other ADC's and national consortia, and data from the NYU ADC is shared with the National Alzheimer's Coordinating Center (NACC) and with numerous collaborating investigators. The ADC has made and will continue to make substantial contributions toward eliminating the problem of AD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A TRIAL OF SIMVASTATIN TO SLOW THE PROGRESSION OF ALZHEIMER'S DISEASE
HIGH DOSE SUPPLEMENTS TO TREAT ALZHEIMER'S DISEASE
ALZHEIMER'S DISEASE DIAGNOSIS: LEUKOCYTE MULTIGENE SIGNATURES
A TRIAL OF SIMVASTATIN TO SLOW THE PROGRESSION OF ALZHEIMER'S DISEASE
海外基金